Bethany Holderread, Associate Director of Clinical Pharmacy at IPD Analytics, presented at the AMCP Great Plains Day of Education.

Jennifer Billings, Senior Director of Clinical Pharmacy at IPD Analytics, presented at the AMCP Great Plains Day of Education (DOE).

Alyssa Guest, Associate Director of Clinical Pharmacy at IPD Analytics, presented, "Bridging Regions, Aligning Stakeholders: Advancing Coordinated Care in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)."

Bethany Holderread will present two sessions at the 2026 AMPAA Annual Conference.

Bethany Holderread, PharmD, Associate Director of Clinical Pharmacy at IPD Analytics, presented at the 2026 Texas Pharmacy Association Conference & Expo.

Some of the most widely prescribed and profit‑generating biologic therapies are set to lose exclusivity over the next few years, yet only a fraction have a biosimilar competitor currently in development.

Sheetal Sheth, PharmD, BCOP, presented "Rends in Commercial Payer Coverage of Accelerated Approval Therapies" poster on behalf of her co-authors Michelle Rogers, PharmD, BCPS, and Irvin Molina, PharmD, BCOP, BCPS, CSP, at Oncology Pharmacists Connect 2026.

Bethany Holderread, PharmD, Associate Director of Clinical Pharmacy at IPD Analytics, presented, "Most Favored Nation: A Closer Look Below the Surface" at the Mississippi Association of Health Plans Annual Conference.

Jeffrey Casberg, MS, RPh, Executive Vice President of Clinical Pharmacy at IPD Analytics, joined the AMCP Northeast Evening of Education panel on May 14, 2026.

Kimberly Grant, Director of Clinical Pharmacy at IPD Analytics, presented at AMCP Northwest Day of Education.

By FirstWord Pharma | Original Article BOSTON, May 4, 2026 - The Institute for Clinical and Economic Review (ICER) posted a Protocol today outlining how it will conduct its second annual analysis titled the “Launch Price and Access Report,” which will examine launch prices and patient access for new FDA-approved treatments. This protocol was developed with input from a multi-stakeholder working group* consisting of patient and consumer advocates, clinicians, policy experts, p

Jeffrey Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy, and Julie Kendle, PharmD, Senior Director of Clinical Pharmacy at IPD Analytics, presented "Pharmaceutical Pipeline Update: What Employers Need to Know" at the Employers Health webinar.

Julie Kendle, Pharm.D., Senior Director of Clinical Pharmacy at IPD Analytics, explains how managed care organizations can support patients at risk of HIV.

Julie Kendle, Senior Director of Clinical Pharmacy at IPD Analytics, explains where managed healthcare organizations should look if they want to improve PrEP access and align with public health goals.

Julie Kendle, Senior Director of Clinical Pharmacy at IPD Analytics, provides an overview of the HIV preventative medicine landscape.

Andrew Levitsky, PharmD, BCPS, and Marina Sehman, PharmD, CSP, at IPD Analytics presented, "Drug Pipeline: Traditional Pharmaceuticals (Brands and Generics) and Biosimilars" at the AMCP Annual Meeting 2026.

Julie Kendle, PharmD at IPD Analytics and Kelsea Aragon, PharmD, PhC, BCACP, CDCES, AAHIVP, at the UNM College of Pharmacy, presented, "Next-Generation HIV PrEP: Therapeutic Advances, Adherence Optimization, and Policy Updates for Managed Care" at the AMCP Annual Meeting 2026.

Alyssa Guest, PharmD, Stephanie Tran, PharmD, MPH, BCPS, and Bethany Holderread, PharmD, presented their award-winning poster, "The Impact of Expanded Indications for Glucagon-Like Peptide 1 Receptor Agonist-Based Anti-Obesity Medications in State Medicaid Fee-For-Service Pharmacy Programs," at the AMCP Annual Meeting 2026 in Nashville, TN.

Managed Healthcare Executive conducted its annual pharmacy survey, capturing perspectives from payers, pharmacy leaders, health systems, academic institutions, government and pharmacy benefit managers (PBMs).

The Academy of Managed Care Pharmacy (AMCP) is pleased to announce a strategic partnership with IPD Analytics.

Jeffrey Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy and Julie Kendle, PharmD, Senior Director of Clinical Pharmacy at IPD Analytics, presented "Pharmaceutical Pipeline Update: What Employers Need to Know" at the Employers Health 2026 Annual Benefits Forum.

Komzifti launched with early commerical traction - generating $2.1 million in net product revenue in the final weeks of 2025 - and achieved rapid market access (payers covering ~84% of private lives and ~90%% of insured lives pre-approval) aided by an NCCN Category 2A listing and fast payer decisions via KuraConnect. By MarketBeat | Original Article Is Kintara Therapeutics A Hidden Gem? Kura Oncology executives used the company's fourth-quarter and fiscal 2025 earnings call t

Sheetal Sheth, PharmD, BCOP, Director of Clinical Pharmacy at IPD Analytics, presented "Building the Precision Medicine Roadmap: Coverage Principles, Value, and the Pipeline Ahead."